Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer

Journal of Cellular Biochemistry

Volumn 91, Issue 3, 2004, Pages 528-539

  Ghosh, Arundhati ^a   Heston, Warren D W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Carboxypeptidase; Dileucine motif; Folate hydrolase; Folylpoly glutamate; Internalization; Prostate specific membrane antigen

Indexed keywords

CLATHRIN; CYTOTOXIN; GAMMA GLUTAMYL HYDROLASE; GLUTAMATE CARBOXYPEPTIDASE II; GLUTAMIC ACID; PROSTATE SPECIFIC MEMBRANE ANTIGEN; RADIOISOTOPE; TUMOR MARKER; ACTIN BINDING PROTEIN; ANDROGEN RECEPTOR; CONTRACTILE PROTEIN; DIPEPTIDE; FILAMINS; FOLIC ACID; GLUTAMATE CARBOXYPEPTIDASE II, HUMAN; MEMBRANE ANTIGEN; N ACETYL 1 ASPARTYLGLUTAMIC ACID; N-ACETYL-1-ASPARTYLGLUTAMIC ACID;

DRUG TARGETING; ENZYME ACTIVITY; GLYCOSYLATION; HUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ALTERNATIVE RNA SPLICING; ANIMAL; BIOLOGICAL MODEL; ENDOCYTOSIS; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, SURFACE; CONTRACTILE PROTEINS; DIPEPTIDES; ENDOCYTOSIS; ENHANCER ELEMENTS (GENETICS); FOLIC ACID; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; MALE; MICE; MICROFILAMENT PROTEINS; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 3843113671     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.10661     Document Type: Review

References (46)

1. Anilkumar G, Rajasekaran SA, Wang S, Hankinson O, Bander NH, Rajasekaran AK. 2003. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res 63:2645-2648.
2. Bacich DJ, Pinto JT, Tong WP, Heston WD. 2001. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase. Mamm Genome 12:117-123.
3. Bander NH, Nanus DM, Milkowsky MI, Kostakoglu L, Vallabahajosula S, Goldsmith SJ. 2003. Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate specific membrane antigen. Semin Oncol (in press).
4. Bzdega T, Turi T, Wroblewska B, She D, Chung HS, Kim H, Neale JH. 1997. Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library. J Neurochem 69:2270-2277.
5. Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Trotot P, Barbat A, Trugnan G. 1992. Dipeptidyl peptidase IV (CD 26) gene expression in enterocyte-like colon cancer cell lines HT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J Biol Chem 267:4824-4833.
6. Dittrich E, Haft CR, Muys L, Heinrich PC, Graeve L. 1996. A di-leucine motif and an upstream serine in the interleukin-6 (IL-6) signal transducer gp130 mediate ligand-induced endocytosis and down-regulation of the IL-6 receptor. J Biol Chem 271:5487-5494.
7. Eto I, Krumdieck CL. 1986. Role of vitamin B12 and folate deficiencies in carcinogenesis. Adv Exp Med Biol 206:313-330.
8. Farrar MA, Schreiber RD. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11:571-611.
9. Ghosh A, Heston WD. 2003a. Role of carbohydrate moieties on biological function of prostate specif membrane antigen/folate hydrolase/glutamate carboxypeptidase II. AACR meeting proceedings 44:980.
10. Ghosh A, Heston WD. 2003b. Role of carbohydrate residues on the folate hydrolase activity of the prostate specific membrane antigen. Prostate 57:140-151.
11. Haft CR, Klausner RD, Taylor SI. 1994. Involvement of dileucine motifs in the internalization and degradation of the insulin receptor. J Biol Chem 269:26286-26294.
12. Haigler HT. 1983. Receptor-mediated endocytosis of epidermal growth factor. Methods Enzymol 98:283-290.
13. Halsted CH, Ling EH, Luthi-Carter R, Villanueva JA, Gardner JM, Coyle JT. 1998. Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem 273:20417-20424.
14. Hirst J, Robinson MS. 1998. Clathrin and adaptors. Biochim Biophys Acta 1404:173-193.
15. Honing S, Sandoval IV, von Figura K. 1998. A di-leucine-based motif in the cytoplasmic tail of LIMP-II and tyrosinase mediates selective binding of AP-3. Embo J 17:1304-1314.
16. Israeli RS, Powell CT, Fair WR, Heston WD. 1993. Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen. Cancer Res 53:227-230.
17. Jennings E. 1995. Folic acid as a cancer-preventing agent. Med Hypotheses 45:297-303.
18. Kawabata H, Yang R, Hirama T, Vuong PT, Kawano S, Gombart AF, Koeffler HP. 1999. Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family. J Biol Chem 274:20826-20832.
19. Kil SJ, Hobert M, Carlin C. 1999. A leucine-based determinant in the epidermal growth factor receptor juxtamembrane domain is required for the efficient transport of ligand-receptor complexes to lysosomes. J Biol Chem 274:3141-3150.
20. Lee SJ, Kim HS, Yu R, Lee K, Gardner TA, Jung C, Jeng MH, Yeung F, Cheng L, Kao C. 2002. Novel prostate-specific promoter derived from PSA and PSMA enhancers. Mol Ther 6:415-421.
21. Leek J, Lench N, Maraj B, Bailey A, Carr IM, Andersen S, Cross J, Whelan P, MacLennan KA, Meredith DM, et al. 1995. Prostate-specific membrane antigen: Evidence for the existence of a second related human gene. Br J Cancer 72:583-588.
22. Letourneur F, Klausner RD. 1992. A novel di-leucine motif and a tyrosine-based motif independently mediate lysosomal targeting and endocytosis of CD3 chains. Cell 69:1143-1157.
23. Liu H, Rajasekaran AK, Moy P, Xia Y, Kim S, Navarro V, Rahmati R, Bander NH. 1998. Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res 58:4055-4060.
24. Ma D, Gardner J, Donovan G, Schuelke N, Hopf C, Cohen M, Fisch D, Olson W. 2003. Fully human anti-PSMA antibodies for prostate cancer therapy. AACR proceedings 44:1295.
25. Marks MS, Ohno H, Kirchhausen T, Bonifacino JS. 1997. Protein sorting by tyrosine-based signals: Adapting to the Ys and wherefores. Trends Cell Biol 7:124-128.
26. Nordeng TW, Gorvel JP, Bakke O. 1998. Intracellular transport of molecules engaged in the presentation of erogenous antigens. Curr Top Microbiol Immunol 232:179-215.
27. O'Keefe DS, Su SL, Bacich DJ, Horiguchi Y, Luo Y, Powell CT, Zandvliet D, Russell PJ, Molloy PL, Nowak NJ, Shows TB, Mullins C, Vonder Haar RA, Fair WR, Heston WD. 1998. Mapping, genomic organization, and promoter analysis of the human prostate-specific membrane antigen gene. Biochim Biophys Acta 1443:113-127.
28. O'Keefe DS, Bachich D, Heston WDW. 2001. Prostate specific membrane antigen. In: Chung LWK, Issacs WB, Simons JW, editors. Prostate cancer, biology, genetics, and the new therapeutics. New Jersey: Humana Press, pp 307-326.
29. Pastan IH, Willingham MC. 1981. Receptor-mediated endocytosis of hormones in cultured cells. Annu Rev Physiol 43:239-250.
30. Pitcher C, Honing S, Fingerhut A, Bowers K, Marsh M. 1999. Cluster of differentiation antigen 4 (CD4) endocytosis and adaptor complex binding require activation of the CD4 endocytosis signal by serine phosphorylation. Mol Biol Cell 10:677-691.
31. Rajasekaran S, Anilkumar G, Oshima E, Bowie JU, Liu H, Bander NH, Heston WD, Rajasekaran AK. 2003. A novel cytoplasmic tail MXXXL motif mediates the internalization and lysosomal targeting of prostate specific membrane antigen. Mol Biol Cell (in press).
32. Rawlings ND, Barrett AJ. 1997. Structure of membrane glutamate carboxypeptidase. Biochim Biophys Acta 1339:247-252.
33. Rinker-Schaeffer CW, Hawkins AL, Su SL, Israeli RS, Griffin CA, Isaacs JT, Heston WD. 1995. Localization and physical mapping of the prostate-specific membrane antigen (PSAf) gene to human chromosome 11. Genomics 30:105-108.
34. Sandoval IV, Bakke O. 1994. Targeting of membrane proteins to endosomes and lysosomes. Trends Cell Biol 4:292-297.
35. Schulke N, Donovan GP, Morrissey DM, Arrigale R, Varlamova O, Scalzo TM, Israel RJ, Heston WDW, Olson WC. 2001. Human prostate specific membrane antigen (PSMA) is naturally expressed as a non covalent dimer. AACR proceedings: New discoveries in prostate cancer biology and treatment A14.
36. Shin J, Dunbrack RL, Jr., Lee S, Strominger JL. 1991. Signals for retention of transmembrane proteins in the endoplasmic reticulum studied with CD4 truncation mutants. Proc Natl Acad Sci USA 88:1918-1922.
37. Shneider BL, Thevananther S, Moyer MS, Walters HC, Rinaldo P, Devarajan P, Sun AQ, Dawson PA, Ananthanarayanan M. 1997. Cloning and characterization of a novel peptidase from rat and human ileum. J Biol Chem 272:31006-31015.
38. Shuba YM, Prevarskaya N, Lemonnier L, Van Coppenolle F, Kostyuk PG, Mauroy B, Skryma R. 2000. Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line. Am J Physiol Cell Physiol 279: C1144-C1154.
39. Silver DA, Pellicer I, Fair WR, Heston WD, Cordon-Cardo C. 1997. Prostate-specific membrane antigen expression in normal and malignant human tissues. Clin Cancer Res 3:81-85.
40. Su SL, Huang IP, Fair WR, Powell CT, Heston WD. 1995. Alternatively spliced variants of prostate-specific membrane antigen RNA: Ratio of expression as a potential measurement of progression. Cancer Res 55:1441-1443.
41. Takash W, Canizares J, Bonneaud N, Poulat F, Mattei MG, Jay P, Berta P. 2001. SOX7 transcription factor: Sequence, chromosomal localisation, expression, transactivation, and interference with Wnt signalling. Nucleic Acids Res 29:4274-4283.
42. Traub LM, Kornfeld S. 1997. The trans-Golgi network: A late secretory sorting station. Curr Opin Cell Biol 9:527-533.
43. Trowbridge IS, Collawn JF, Hopkins CR. 1993. Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol 9:129-161.
44. Wissenbach U, Niemeyer BA, Fixemer T, Schneidewind A, Trost C, Cavalie A, Reus K, Meese E, Bonkhoff H, Flockerzi V. 2001. Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. J Biol Chem 276:19461-19468.
45. Wright GL, Jr., Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, Troyer J, Konchuba A, Schellhammer PF, Moriarty R. 1996. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 48:326-334.
46. Yao R, Schneider E, Ryan TJ, Galivan J. 1996. Human gamma-glutamyl hydrolase: Cloning and characterization of the enzyme expressed in vitro. Proc Natl Acad Sci USA 93:10134-10138.